PMID: 11906765DOI: 10.1016/s0264-410x(02)00025-7Mar 22, 2002Paper
Estimating the potential health gain and cost consequences of introducing a pre-school DTPa pertussis booster into the UK child vaccination schedule
Vaccine
Matt StevensonAlan Brennan
Abstract
This work estimates the health and cost impacts of a pre-school booster vaccination for Bordetella pertussis, when added to existing UK primary vaccination. A transition state simulation model of pertussis infection in a closed population was constructed comprising of susceptible, infected and immune population sub-groups, across eight age bands. Epidemiological, service use and cost data were sourced from routine statistics, published literature and clinician estimates. The introduction of a pre-school booster is predicted to reduce the number of hospitalisations by approximately 1400 and pertussis cases suffered by up to 28,000 at a net investment of under 13 million pounds over a 5-year period.
References
Jan 17, 1976·British Medical Journal·C L Miller, W B Fletcher
Jul 1, 1991·Archives of Disease in Childhood·S R Palmer
Feb 27, 1988·British Medical Journal·D Jenkinson
Feb 4, 1995·BMJ : British Medical Journal·D Jenkinson
Feb 1, 1995·Soins. Pédiatrie, puériculture
Jun 13, 1998·European Journal of Pediatrics·C H Wirsing von KönigH J Schmitt
Jul 31, 1998·Vaccine·S SalmasoD Greco
Apr 8, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·U HeiningerJ D Cherry
May 18, 1999·Archives of Disease in Childhood·S RanganathanJ Britto
A randomised controlled trial with a diphtheria-tetanus-acellular pertussis (dTpa) vaccine in adults
Mar 15, 2000·Vaccine·M Van der WielenA Ramalho
Nov 15, 2000·Journal of Public Health Medicine·S M Beard, A Finn
Nov 25, 2000·Vaccine·F M TurnbullA C Ramalho
❮ Previous
Next ❯
Citations
Mar 19, 2009·International Journal of Health Care Finance and Economics·Dorota Zdanowska Girard
Jun 14, 2005·Health Policy·Dorota Zdanowska Girard
Mar 6, 2004·Trends in Microbiology·Michiel van BovenAnnelies van Rie
May 7, 2005·The Pediatric Infectious Disease Journal·J Jaime CaroEvelinda Trindade
Oct 27, 2010·PloS One·Robin de VriesMaarten J Postma
May 8, 2002·Paediatric Drugs·Dorota Z Girard
Dec 4, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kevin D ForsythUNKNOWN Global Pertussis Initiative
Mar 30, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Michael HerdmanNancy Devlin
Oct 7, 2008·Vaccine·Iria Rodríguez-CoboIan Litchfield
Aug 19, 2007·Preventive Medicine·Hye-Youn ParkKiyoung Lee
Jul 21, 2012·Expert Review of Pharmacoeconomics & Outcomes Research·Josephine MauskopfBaudouin Standaert
Dec 23, 2006·Risk Analysis : an Official Publication of the Society for Risk Analysis·Kimberly M Thompson, Radboud J Duintjer Tebbens
Nov 2, 2017·Cost Effectiveness and Resource Allocation : C/E·Melanie Y BertramTessa Tan-Torres Edejer
Mar 27, 2021·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Elise TessierGayatri Amirthalingam
❮ Previous
Next ❯
Related Concepts
Related Feeds
Related Papers
Vaccine
W John EdmundsNigel J Gay
Vaccine
P BeutelsP C Crovari
The Cochrane Database of Systematic Reviews
Linjie ZhangS A Halperin
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Sarah Jeurissen, Amin Makar